Arkolith/Insider Trading/RNXT/Form 4

Agah Ramtin

Chief Medical Officer, DirectorRenovoRx, Inc. (RNXT) · full profile →Form 4 · filed Nov 24, 2025
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 24, 2025Buy(P)12K$0.80$10K756K
Nov 21, 2025Buy(P)10K$0.80$8K744K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-024875) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML